Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Glioblastoma Multiforme (GBM)

NCT03630289 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT03630289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03630289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Glioblastoma Multiforme (GBM)
Lead sponsor
Northwell Health
Phase
Not applicable
Overall status
Completed
Start date
July 27, 2018
Completion date
March 26, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, gbm, glioblastoma, glioblastoma multiforme